Ordinary Rebalance | Solactive Transatlantic Healthcare Equity Index | Effective Date 8th January 2024
In the ordinary rebalance, the following composition will be implemented effective open 08.01.2024:
ABBOTT LABORATORIES |
ABBVIE INC |
ALCON INC |
AMEDISYS INC |
AMGEN INC |
BECTON DICKINSON AND CO |
BIOGEN INC |
BRISTOL-MYERS SQUIBB CO |
CENTENE CORP |
COLOPLAST AS CLASS B |
CONVATEC GROUP PLC |
COOPER COMPANIES INC |
DANAHER CORP |
ELEVANCE HEALTH INC |
ENCOMPASS HEALTH CORP |
ENSIGN GROUP INC |
ESSILORLUXOTTICA |
GETINGE AB CLASS B |
GILEAD SCIENCES INC |
GSK PLC |
HOLOGIC INC |
HUMANA INC |
IQVIA HOLDINGS INC |
JOHNSON & JOHNSON |
LABORATORY CRP OF AMER HLDGS |
MEDTRONIC PLC |
MERCK & CO. INC. |
MOLINA HEALTHCARE INC |
NEUROCRINE BIOSCIENCES INC |
NOVARTIS AG |
PFIZER INC |
PRESTIGE CONSUMER HEALTHCARE INC |
QIAGEN NV |
QUEST DIAGNOSTICS INC |
RECORDATI SPA |
REGENERON PHARMACEUTICALS |
ROCHE HOLDING AG |
ROYALTY PHARMA PLC- CL A |
SIEMENS HEALTHINEERS AG |
SONOVA HOLDING AG |
STERIS PLC |
STRYKER CORP |
SWEDISH ORPHAN BIOVITRUM AB |
THERMO FISHER SCIENTIFIC INC |
UCB SA |
UNITED THERAPEUTICS CORP |
UNITEDHEALTH GROUP INC |
VIATRIS INC |
ZIMMER BIOMET HOLDINGS INC |
ZOETIS INC |